Myasthenia gravis during low-dose IFN-α therapy for chronic hepatitis C

Journal of Interferon and Cytokine Research

Volumn 21, Issue 7, 2001, Pages 469-470

  Borgia, Guglielmo ^a,b   Reynaud, Laura ^a   Gentile, Ivan ^a   Cerini, Raimondo ^a   Ciampi, Rocco ^a   Dello Russo, Massimo ^a   Piazza, Marcello ^a  

^a UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^b Institute for Infectious Diseases via Pansini   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOTRANSFERASE; CHOLINERGIC RECEPTOR ANTIBODY; CYCLOSPORIN; HEPATITIS C ANTIBODY; PYRIDOSTIGMINE; RECOMBINANT ALPHA INTERFERON; VIRUS RNA;

ADULT; AMINOTRANSFERASE BLOOD LEVEL; ANXIETY; ARTICLE; ASTHENIA; CASE REPORT; CLINICAL FEATURE; DIPLOPIA; DISEASE ASSOCIATION; DISEASE COURSE; DRUG SAFETY; DRUG WITHDRAWAL; HEADACHE; HEPATITIS C; HEPATITIS C VIRUS; HOSPITALIZATION; HUMAN; HUMAN TISSUE; LIVER BIOPSY; MALE; MYASTHENIA GRAVIS; NON INSULIN DEPENDENT DIABETES MELLITUS; PORPHYRIA CUTANEA TARDA; PRIORITY JOURNAL; TREATMENT OUTCOME;

ANTIVIRAL AGENTS; DRUG ADMINISTRATION SCHEDULE; HEPATITIS C, CHRONIC; HUMANS; INTERFERON TYPE I, RECOMBINANT; MALE; MIDDLE AGED; MYASTHENIA GRAVIS;

HEPATITIS C VIRUS;

EID: 0034828776     PISSN: 10799907     EISSN: None     Source Type: Journal    
DOI: 10.1089/10799900152434321     Document Type: Article

References (13)

1. Epatite virale acuta e cronica
2. Terapia delle epatiti croniche virale
3. IFN-α therapy is effective in suppressing the clinical experimental myasthenia gravis
4. Cytokines and the pathogenesis of myasthenia gravis
5. IFN-alpha treatment suppresses the development of experimental autoimmune myasthenia gravis
6. Low dose of interferon-α is safe in patients with myasthenia gravis
7. α-interferon treatment in myasthenia gravis: Effects on natural killer cell activity
8. Myasthenia gravis during interferon α therapy
9. Oculo-bulbar myasthenia gravis induced by cytokine treatment of a patient with metastasized renal cell carcinoma
10. Myasthenia gravis in a patient with chronic active hepatitis C during interferon-α treatment
11. Development of myasthenia gravis during interferon-α treatment for anti-HCV positive chronic hepatitis
12. Myasthenia gravis and hepatitis C virus infection
13. Untreated hepatitis C may provoke myasthenia gravis